Ramipril and Urinary bladder haemorrhage - a phase IV clinical study of FDA data

Summary:

Urinary bladder haemorrhage is reported as a side effect among people who take Ramipril (ramipril), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Imbruvica, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Urinary bladder haemorrhage when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,394 Ramipril users. Check the latest studies of Ramipril.

What is Urinary bladder haemorrhage?

Urinary bladder haemorrhage (urinary bladder bleeding) is found to be associated with 297 drugs and 464 conditions by eHealthMe. Check the latest studies of Urinary bladder haemorrhage.

On May, 05, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 27 people (0.02%) have Urinary bladder haemorrhage.

Could Ramipril cause Urinary bladder haemorrhage?

Among these 27 people:

How long have people been on Ramipril when they have Urinary bladder haemorrhage? *

Click here to view more results

What is the gender of people who have Urinary bladder haemorrhage when taking Ramipril? *

Click here to view

What is the age of people who have Urinary bladder haemorrhage when taking Ramipril? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Urinary bladder haemorrhage?

- Check whether Urinary bladder haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,394 reports)

Urinary bladder haemorrhage treatments and more:

Urinary bladder haemorrhage (2,610 reports)

How severe was Urinary bladder haemorrhage and when was it recovered:

Urinary bladder haemorrhage in Ramipril

Expand to all the drugs that have ingredients of ramipril:

Urinary bladder haemorrhage and drugs with ingredients of ramipril (20 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary bladder haemorrhage:

Urinary bladder haemorrhage (297 drugs)

Browse all the conditions that are associated with Urinary bladder haemorrhage:

Urinary bladder haemorrhage (464 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.